US Patent Issued to REGENERON PHARMACEUTICALS on Feb. 17 for "Anti-PCRV antibodies that bind PCRV, compositions comprising anti-PCRV antibodies, and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,856, issued on Feb. 17, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Anti-PCRV antibodies that bind PCRV, compositions comprising anti-PCRV antibodies, and methods of use thereof" was invented by Christos Kyratsous (Irvington, N.Y.) and Alida Coppi (Flushing, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies and antigen-binding fragments of antibodies that bind to Pseudomonas aeruginosa PcrV, and methods of using the same. According to certain embodiments, the disclosure includes antibodies and antigen-binding fragments of antibodies that bind PcrV. The anti-PcrV antibodies and antig...